MCSGP shows promise in addressing one of AAV manufacturing's greatest conundrums — separating full capsids from the empty and partially-filled ones.
- Five APAC Markets, Five Regulatory Models: What Developers Should Know
- Applying The Multiproduct Manufacturing Model To Autologous Cell Therapy
- You Can't CAPA What You Can't Locate
- Safety, Durability, And Trial Design: Testing One-Time Dose To Slow Huntington's
- Computational Model Predicts Huntington's Drug Performance
- Comparing Advanced Modality Needs, Part 1: Manufacturing
- What Will It Take To Turn CGT Innovation Into Market Success?
- Why CMC Must Shape Critical Decisions Early In Development
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Chromatography Resin – Stability And Resin Life Cycle
Protein A resin lifetime drives resin volume and process cost. Repeated caustic cleaning and regeneration cycles test whether binding capacity and impurity clearance hold up across competing resins.
-
Improved Methods For CRISPR-Cas9 Homology-Directed Repair
Precise genome editing depends on improving HDR efficiency. Learn how guide selection, template design, homology arm optimization, and delivery strategies work together to drive higher-fidelity edits.
-
GLP-1 Peptides Around The World
Explore how evolving regulations, supply constraints, and reimbursement models shape GLP-1 drug development across the U.S., Europe, and Asia.
-
Partner Case Study: Accelerating Gene Editing Manufacturing
Beam Therapeutics partnered with ElevateBio to manufacture BEAM-101, a novel base editing therapy for sickle cell disease, advancing rapid, high-quality production towards clinical trials.
-
Standardizing Cryopreservation For Cell Therapy Supply Chains
Explore how a standardized cryopreservation process is transforming leukapheresis handling by reducing risk and improving quality across the cell therapy supply chain.
-
Flexible Multiplex Solution For VCN Determination In Gamma-Retrovirus–Transduced CAR-T Cells Using QIAcuity® dPCR
See how a multiplex digital PCR approach enables accurate, reproducible VCN determination in gamma‑retrovirus–transduced CAR‑T cells, supporting streamlined workflows and confident decision‑making.
-
From Variability To Validation – GMP Bioassay Success Through Partnership
Turn your inconsistent bioassays into GMP-validated, high-reliability platforms — just like we helped a biopharma partner cut failure rates from ~25% to <1%.
-
Expansion Of Human Bone Marrow-Derived MSCs
Achieving over 870 million viable, quality mesenchymal stem/stromal cells is possible. This efficient cell culture method scales bone marrow-derived MSCs for clinical needs.
-
Advancing Downstream Purification
Aggregate and variant clearance for bispecifics, ADCs, and fusion proteins looks different with frontal-mode cation exchange and mixed-mode selectivity, including fewer process steps.
-
Filling Syringes With Spray-Dried Powders - The How, The Why And The Benefits
Discover how filling spray-dried powders directly into syringes improves stability, minimizes cold chain reliance, and accelerates administration speeds for critical therapies.
NEWSLETTER ARCHIVE
- 11.20.26 -- Want More Sustainable Biopharma Packaging? Try These Levers
- 11.19.26 -- OPCU: Strengthening Large Molecule Programs From Manufacturing To Fill-Finish
- 11.19.26 -- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 2
- 11.18.26 -- OPCU: Strengthening Cell And Gene Therapy Programs With Robust Analytics
- 11.18.26 -- What Will It Take To Turn CGT Innovation Into Market Success?
- What Will It Take To Turn CGT Innovation Into Market Success?
- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 2
- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 1
- Earlier Decisions, Better Processes Required For Automating Autologous CAR T Manufacturing
- Why In Vivo Innovation, Regulatory Convergence Will Help Shape CGT's Next Chapter
EDITORIAL COLLECTIONS KNOWLEDGE CENTER
Our Editorial Collections examine today’s biggest scientific, operational, and patient-centered drug delivery issues. These collections help companies navigate complex development decisions with in-depth analysis, real-world examples, and guidance from industry experts
More Editorial Collections

